Following representations by Community Pharmacy England (CPE) on behalf of pharmacies, the Department of Health and Social Care (DHSC) has redetermined the reimbursement prices for Jext and Priadel preparations for July 2023 to reflect an increase in their NHS list price. On 1st July 2023 the list prices for Jext preparations were increased by the
Read moreDrug alert number: EL (23)A/27 Date issued: 31 July 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: various products manufactured by B.Braun Ltd. Gentamicin 3mg/ml solution for infusion, PL 03551/0117 Batch number Expiry date Pack size First distributed 21025402 31/12/2023 120ml Ecoflac Plus 01/03/2021 21056410 31/01/2024
Read moreCommunity Pharmacy England would like to remind pharmacy teams of the importance of submitting the FP34C declaration through the Manage Your Service (MYS) portal no later than the 5th of each month (or the 6th where a bank holiday occurs during the first five days of the month) following that in which supply was made.
Read moreNational Patient Safety Alert: Potent synthetic opioids implicated in heroin overdoses and deaths National Patient Safety Alert Reference Number: NatPSA/2023/009/OHID Date issued: 26th July 2023 Brief description of the problem In the past 8 weeks there has been an elevated number of overdoses (with some deaths) in people who use drugs, primarily heroin, in many
Read moreThe Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 August 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n
Read moreChemist+Druggist have today published a second article in which the Chief Executive of the Association of Independent Multiple Pharmacies (AIM) makes a series of comments about Community Pharmacy England and other national pharmacy organisations. We are publishing our response to the commentary here and Community Pharmacy England’s Chair is writing to AIM’s Chair to seek
Read moreA new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 12 July 2023) has been published and includes articles on: Hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch): risk of anticholinergic side effects, including hyperthermia. Codeine linctus: public consultation on the proposal to reclassify to a prescription-only medicine.
Read moreIn our latest blog, Community Pharmacy England Committee Member and Regional Representative for Yorkshire and Humber David Broome, provides insight on the key topics discussed at our July Committee meeting. The update explains the urgent matters discussed during the meeting such as the ongoing pressures on community pharmacy businesses and staff, as well as describing
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (21/07/2023) announced the following list of price concessions for July 2023: Please note CPE is still in discussion with DHSC on several other lines of concern, including other
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Atomoxetine 40mg and 60mg capsules. MSN/2023/068 Tier 2 – medium impact Date of issue 21st July 2023 Atomoxetine 40mg and 60mg capsules will be out of stock from late July 2023 until September 2023 Other strengths and formulations of atomoxetine remain
Read more
